That is, more CD40 on the surface of B cells (as is the case for carriers of the RA risk allele) has increased activation of the classical NF-κB pathway (as measured by phosphorylation of NF-κB p65). The gene discussed is NFKB1; the disease is rheumatoid arthritis.